Clinical Efficacy of External Counterpulse Therapy and the effect on Vascular Endothelial Function in Patients with Primary Hypertension: an explorative randomized, double blinded, controlled pilot st

Ruian hospiytal of traditional Chinese medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Age 35-80 (including 35 and 80), gender is not limited
•2. According to the Chinese Guidelines for the Prevention of Hypertension (Revised 2018),Patients diagnosed with primary hypertension levels 1-2
•3. Understand and sign informed consent form
•Note: The above three items must be met at the same time before they can be included in the study.

•1. In contraindications of anti-pulse therapy :Hypertension grade 2 or higher; severe heart failure, 1 month history of heart infarction, severe aortic valve insufficiency, atrial fibrillation and frequent ventricular velocity.
•2. Take medication that affects blood pressure fluctuations: e.g. have been taking birth control pills for less than three months.
•3. Secondary hypertension: renal parenchyma and renal vascular hypertension, endocrine hypertension, aortic constriction, obstructive sleep apnea hypoventilation syndrome, pharmacogenic hypertension (including female contraceptives, eugene, partial diet pills, left dopa, non-dixie drugs, glucocorticoids, partial immunosuppressants, erythropoietin, etc.).
•4. Unable or unwilling to comply with the study plan
•Note: any items that meet the requirements should be excluded.

发起方

Ruian hospiytal of traditional Chinese medicine